Overview

Provides readers with a framework to understand and analyze several medicine pricing policies. Through case studies from countries across geographies and income tiers, this book explores the challenges and opportunities related to price control experiences. Studying global policies this book discusses approaches, strategies, and the underlying pharmaceutical pricing practices used to provide advice for formulating highly effective policies. Alongside the cases, this book covers appropriate research methods for pricing analysis, the essential components of pricing policy, data quality, and the generic structure of a pharmaceutical pricing policy.

Full Product Details

Author:   Zaheer-Ud-Din Babar (Professor in Medicines and Healthcare, Director, Centre for Pharmaceutical Policy and Practice Research, Department of Pharmacy, University of Huddersfield, UK)
Publisher:   Elsevier Science Publishing Co Inc
Imprint:   Academic Press Inc
Weight:   0.450kg
ISBN:  

9780443235184

ISBN 10:   044323518
Pages:   364
Publication Date:   01 August 2025
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Forthcoming
Availability:   Not yet available  
This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release.

Table of Contents

1. An update on pharmaceutical pricing policies: latest research and evidence synthesis 2. Research methods used in pharmaceutical pricing research 3. Implementation of pharmaceutical pricing policies in NZ: Lessons learned 4. Australia's progress in pharmaceutical pricing policies 5. Components of a successful pricing policy in high-income countries 6. Outlining the components of a pricing policy for the US: a proposal 7. Lessons learned from China on medicine pricing policies 8. Synthesis chapter on EU Pharmaceutical pricing policies 9. Challenges in Low and Middle-Income Countries regarding pharmaceutical pricing policies 10. South Africa's medicine pricing policies: implementation strategies and models 11. Pharmaceutical pricing policies in countries with price control (Pakistan, India, Bangladesh): lessons learned 12. Challenges in the implementation of pharmaceutical pricing policies 13. Issues with medicine pricing data about pharmaceutical pricing policies in LMICs 14. Optimal pharmaceutical pricing policies in low and middle-income countries 15. Formulating a medicines pricing policy of a country: essential components, what to include 16. Synthesis, conclusion, and future recommendation

Reviews

Author Information

Professor Zaheer Babar is a Professor of Clinical Pharmacy and Practice at the College of Pharmacy, Qatar University, and serves as a Visiting Professor in the Department of Pharmacy at the University of Huddersfield in the United Kingdom. He has extensively published research on medicine pricing and access to medications, gaining international recognition for his contributions to pharmaceutical policy. Professor Babar has collaborated with organizations such as the United Nations Development Programme (UNDP), Health Action International, Management Sciences for Health (MSH), the International Union Against Tuberculosis and Lung Disease, and the World Bank to develop medicine pricing policies for various countries. His edited work include “Economic Evaluation of Pharmacy Services,” “Pharmaceutical Prices in the 21st Century,” “Pharmaceutical Policies in Countries with Developing Healthcare Systems,” “Global Pharmaceutical Policy,” “Access to High-Cost Medicines,” “Pharmacy Practice Research Methods,” “Pharmacy Practice Research Case Studies,” “Encyclopedia of Pharmacy Practice and Clinical Pharmacy.” And “Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy.”

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions